WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2003060111) CANCER-SPECIFIC MUTANTS OF B-RAF GENES AND USES THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2003/060111    International Application No.:    PCT/GB2002/005921
Publication Date: 24.07.2003 International Filing Date: 24.12.2002
IPC:
C12Q 1/68 (2006.01)
Applicants: CATALYST BIOMEDICA LIMITED [GB/GB]; 183 Euston Road, London NW1 2BE (GB) (For All Designated States Except US).
STRATTON, Mike [GB/GB]; (GB) (For US Only).
FUTREAL, Andy [GB/GB]; (GB) (For US Only).
WOOSTER, Richard [GB/GB]; (GB) (For US Only).
MARAIS, Richard, Malcolm [GB/GB]; (GB) (For US Only).
MARSHALL, Chris [GB/GB]; (GB) (For US Only)
Inventors: STRATTON, Mike; (GB).
FUTREAL, Andy; (GB).
WOOSTER, Richard; (GB).
MARAIS, Richard, Malcolm; (GB).
MARSHALL, Chris; (GB)
Agent: MASCHIO, Antonio; D Young & Co, 21 New Fetter Lane, London EC4A 1DA (GB)
Priority Data:
60/344,684 24.12.2001 US
Title (EN) CANCER-SPECIFIC MUTANTS OF B-RAF GENES AND USES THEREOF
(FR) GENES
Abstract: front page image
(EN)The invention relates to mutations in B-Raf gene products. The mutations described are identified in human tumours of natural origin. These mutations are associated with cancerous phenotypes and can be used as a basis for the diagnosis of cancer, cancerous cells or a predisposition to cancer in human subjects, and the development of anti-cancer therapeutics.
(FR)L'invention se rapporte à des mutations dans des produits du gène B-Raf. Les mutations décrites sont identifiées dans des tumeurs humaines d'origine naturelle. Ces mutations sont associées à des phénotypes cancéreux et peuvent être utilisées en tant que base pour le diagnostic du cancer, de cellules cancéreuses ou d'une prédisposition au cancer chez des êtres humains, et pour le développement de méthodes thérapeutiques contre le cancer.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)